$3900 | Site License
$7800 | Global License

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies
[Lowest Price Guaranteed: $3,900]

Published by FirstWord Pharma: 02 Dec 2014 | 176 | In Stock
Related Topics: Breast Cancer , Cancer , Internet , Lung Cancer , Medical , Melanoma , Products , Renal Cell Carcinoma

Introduction

Introduction


As the cancer drug market continues to face significant challenges in an environment of rising R&D costs, value-based pricing, demands for real world evidence and tougher regulation, the role of Medical Affairs teams in oncology working across the major markets of Europe – France, Germany, Italy, Spain and the UK; EU5 – becomes ever more critical.


Honing performance through smarter delivery, higher quality interaction, and effective communication with oncologists is vital for ensuring optimal performance levels of Medical Affairs teams.


In Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies, FirstWord provides robust insight on the performance and level of physician satisfaction with Medical Affairs teams representing 12 products in 4 key indications – Breast Cancer, Melanoma, Non-Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma – across Europe’s most important markets.


Using proprietary analytics, EdgeMap and Need-Gap analysis, FirstWord offers important advanced analysis of the latest physician opinions on Medical Affairs that is both timely and critical for success in today’s oncology drugs markets.


Puchase Reasons


Key Benefits


  • Gain insight into how EU5 oncologists and haematologist-oncologists rate Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC and Renal Cell Carcinoma

  • GUnderstand the key issues for which physicians require Medical Affairs team support

  • GLearn which attributes physicians value most in relation to Medical Affairs team services

  • GIdentify which marketed and pipeline products were rated highest across numerous measures

  • GContrast and compare performance of Medical Affairs teams on multiple parameters – services, brand, indication and country

  • GDetermine which media and frequency of interaction is perceived most positively

  • GBenefit from FirstWord's proprietary advanced analytics, EdgeMap and Need-Gap, to identify relative competitive positons and opportunities to develop advantage

  • GDetailed multi-level comparative analysis of European Medical Affairs teams versus their US counterparts

  • Report Features


    Filled with charts and up-to-the-minute survey analysis, this report offers:


  • Precise and timely EdgeMap and Need-Gap analysis of oncologists' perceptions of Medical Affairs teams highlighting good and bad performance and identifying key areas for improvement

  • Overview of key rankings for eight marketed and four pipeline products

  • Examination of physicians' current touch points with Medical Affairs teams

  • Key findings regarding the attributes of Medical Affairs teams physicians value most and least

  • Comparative analysis of EU5 and US Medical Affairs teams at brand and attribute levels

  • Get Answers to Key Questions


  • How do oncologists perceive the role of Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC and Renal Cell Carcinoma?

  • How do physicians use the services of Medical Affairs teams?

  • What is the optimal frequency of interactions between Medical Affairs teams and physicians?

  • Within the competitive landscape of the EU5, what is each product’s position in terms of Medical Affairs services and support?

  • Which attributes of Medical Affairs teams are most likely to drive competitive advantage?

  • Which drugs provide the best service and claimed the highest ratings for Medical Affairs support?

  • What are the opportunities for corporate and brand positioning, and communication?

  • Key Takeaways


    Medical Affairs teams, Marketing Directors and Competitive Intelligence units can use this report to:


  • Precisely analyse physician needs and areas of concern

  • Improve team responsiveness and traction with oncologists

  • Deliver more effective messaging and tackle areas of weakness

  • Provide accurate, scientifically up-to-date product information in the areas of the most need

  • Understand how competitors are performing, where their performance leads or lags that of your team, and how big the gaps are

  • Tailor interaction frequency, media and approach

  • What is EdgeMap Analysis?


    This report includes advanced analysis of oncologists’ perceptions of Medical Affairs teams collected via an online survey. EdgeMap analysis, a proprietary analytics tool, provides an integrated, comparative analysis of the competitive set of products and attributes being evaluated in the study. It offers an overview of the market and provides a clear portrait of each product’s position within its competitive environment


    What is Need-Gap Analysis?


    This report includes slides that provide advanced analysis of oncologists’ perceptions of Medical Affairs teams collected via an online survey. Need-Gap analysis, a proprietary analytics tool, pinpoints areas of unmet need and provides valuable guidance on opportunities for corporate and brand positioning, and communication.



    Key Fact: Interviewing Methodology


    Data was collected via a 15-minute Internet-based questionnaire.


    Key Fact: Sample Distribution


    210 medical oncologists and haematologist-oncologists across EU5 participated in this study.

    Key Fact: Screening Criteria


  • Have been in active practice between 5-35 years

  • Devote at least 50% of time to direct patient care

  • Have had direct interaction with a medical affairs professional in the past 6 months for at least one of the listed products

  • About FirstView Reports


    FirstView Reports deliver two types of research and analysis: FirstView Advisory and FirstView Trends. FirstView Advisory reports are based on the qualitative insights of 10-15 leading experts, including treating and key opinion leading physicians, payers and industry stakeholders. FirstView Trends reports deliver insights based on quantitative market research which leverages FirstWord’s 1-million strong online physician community. FirstView Advisory and FirstView Trends reports deliver authoritative, actionable insight that can help industry professionals understand future pharma market dynamics and support effective decision making.


    About FirstWord Reports


    FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors, and your markets. Covering market access, biosimilars, medical affairs, pharma sales and marketing and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

    Table of Contents
    for Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

    • 1.Current Status of Interactions with Different Medical Affairs Teams

      1.1.Interactions in the past 6 months with Medical Affairs teams for each product

      1.2.Physicians’ current usage of services provided by Medical Affairs teams

      1.3.Frequency of interactions with Medical Affairs teams for each product

      2.Competitive Evaluation of Medical Affairs Teams Performance on Various Attributes

      2.1.Evaluation of overall quality of interactions with Medical Affairs teams for each product

      2.2.Attribute importance of Medical Affairs teams’ role to physicians’ practice

      2.3.EdgeMap analysis by therapy area - competitive evaluation on Medical Affairs teams performance on attributes

      2.4.Competitive evaluation of physicians satisfaction of interaction with Medical Affairs teams

      2.5.Need-Gap analysis by product

      3.Preferred Interaction Media, Frequency and Suggestions for Improvement

      3.1.Preferred interaction media and frequency

      3.2.Suggestions for improvement

      4.Appendix

      4.1.Physician profile

      4.2.Detailed satisfaction scores

    Additional Details

    Publisher

    FirstWord Pharma

    Publisher Information

    Reference

    176 |

    Report Format

    PDF

    FirstWord Pharma Reports

    Related Reports

    TitleDate PublishedPrice fromMore Details
    Medical Affairs Reputations (US): Multiple Sclerosis
    IntroductionCompare how well pharma Medical Affairs teams perform and find out which ones physicians...
    01 Jul 2015 by FirstWord Pharma USD $5,995 More Info
    Building Strong Cross-Functional Medical Affairs Teams
    IntroductionCould your Medical Affairs team be better integrated for more effective cross-functional...
    01 May 2015 by FirstWord Pharma USD $695 More Info
    Medical Affairs Reputation (EU5): Biosimilar mAbs in Inflammatory Disorders
    IntroductionBased on survey results from 150 rheumatologists, dermatologists, and gastroenterologist...
    01 Feb 2015 by FirstWord Pharma USD $5,995 More Info
    Physician Views: How do endocrinologists value diabetes-focused medical affairs teams – what could they be doing better?
    Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
    08 Dec 2014 by FirstWord Pharma USD $695 More Info
    Reshaping Medical Affairs: delivering value to KOLs and payers
    IntroductionHistorically, the key role of Medical Affairs was supporting the initial regulatory appr...
    21 Aug 2014 by FirstWord Pharma USD $695 More Info
    Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
    IntroductionAs the oncology drug market continues to face significant road bumps in terms of develop...
    14 Aug 2014 by FirstWord Pharma USD $3,900 More Info
    Physician Views: How do pulmonologists value medical affairs teams – what could they be doing better?
    Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
    09 Jul 2014 by FirstWord Pharma USD $695 More Info
    Physician Views: How do neurologists value multiple sclerosis medical affairs teams – what could they be doing better?
    Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
    18 Jun 2014 by FirstWord Pharma USD $695 More Info
    Physician Views: How do oncologists value medical affairs teams – what could they be doing better?
    Scope Medical affairs teams are playing an increasingly critical role for pharmaceutical manufacture...
    22 May 2014 by FirstWord Pharma USD $695 More Info
    Ensuring Optimal Medical Affairs Performance: Delivering Measurable Value
    IntroductionIn this era of transparency, Medical Affairs is rapidly becoming the new voice of Pharma...
    01 May 2013 by FirstWord Pharma USD $695 More Info

    This report is published by FirstWord Pharma

    Download Free Report Summary PDF

    Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies | Download PDF Summary

    Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

    Ordering Information

    Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

    Accepted Card Types

    Payment

    Buy now using our secure payment system.

    We Stock...